◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Santen Pharmaceutical Co., Ltd. (4536)
来自官方财务报表的收入、利润与现金流历史。
Healthcare · 华尔街（美国） · 最近更新： 2026-10-02
Santen Pharmaceutical Co., Ltd. engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally. The company operates through Medical drugs, Over-the-counter drugs, Medical equipment, and others segments.
关键数据
- 市值: JPY 529 billion
- 收入（截至 2026-03-31 财年）: JPY 291.6B
- 净利润: JPY 37.4B
- 毛利率: 58.2%
- 净利率: 12.8%
查看交互式图表与完整报表 →
估值模型 (DCF) →
年度利润表
| 利润表 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|
| 总收入 | JPY 291.6B | JPY 300.0B | JPY 302.0B | JPY 279.0B |
| 毛利 | JPY 169.7B | JPY 171.0B | JPY 178.7B | JPY 166.1B |
| 营业利润（EBIT） | JPY 47.8B | JPY 46.9B | JPY 38.5B | (JPY 3.1B) |
| 净利 | JPY 37.4B | JPY 36.3B | JPY 26.6B | (JPY 14.9B) |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 4536 交互式查看器。 /companies/us/4536
类似公司
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.